Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis.
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2011
At a glance
- Drugs Tacrolimus (Primary)
- Indications Lupus nephritis
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 08 Apr 2011 New trial record